Efficacy and safety of pulmonary vein isolation with pulsed field ablation vs. novel cryoballoon ablation system for atrial fibrillation
Europace · 06.12.2023 · 25 (12)
DOI: 10.1093/europace/euad329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Europace, online erschienen am 30.11.2023. Verfasst von Patrick Badertscher und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pulmonary Veins, Cryosurgery, Catheter Ablation. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss Heart Foundation.
Abstract (Originalsprache)
Aims
Pulsed-field ablation (PFA) has emerged as a novel treatment technology for patients with atrial fibrillation (AF). Cryoballoon (CB) is the most frequently used single shot technology. A direct comparison to a novel CB system is lacking. We aimed to compare pulmonary vein isolation (PVI) using PFA vs. a novel CB system regarding efficiency, safety, myocardial injury, and outcomes. Methods and results One hundred and eighty-one consecutive patients underwent PVI and were included (age 64 ± 9.7 years, ejection fraction 0.58 ± 0.09, left atrial size 40 ± 6.4 mm, paroxysmal AF 64%). 106 patients (59%) underwent PFA (FARAPULSE, Boston Scientific) and 75 patients (41%) underwent CB ablation (PolarX, Boston Scientific). The median procedure time, left atrial dwell time and fluoroscopic time were similar between the PFA and the CB group with 55 [interquartile range (IQR) 43–64] min vs. 58 (IQR 48–69) min (P < 0.087), 38 (30–49) min vs. 37 (31–48) min, (P = 0.871), and 11 (IQR 9.3–14) min vs. 11 (IQR 8.7–16) min, (P < 0.81), respectively. Three procedural complications were observed in the PFA group (two tamponades, one temporary ST elevation) and three complications in the CB group (3× reversible phrenic nerve palsies). During the median follow-up of 404 days (IQR 208–560), AF recurrence was similar in the PFA group and the CB group with 24 vs. 30%, P = 0.406.
Conclusion
Procedural characteristics were very similar between PFA and CB in regard to procedure duration fluoroscopy time and complications. Atrial fibrillation free survival did not differ between the PFA and CB groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.
- Cardiovascular Research Institute Basel, University Hospital Basel, Spitalstrasse 2, 4056 Basel, Switzerland.
ORCID-Profile: Patrick Badertscher, Simon Weidlich, Sven Knecht, Niklas Stauffer, Philipp Krisai, Gian Voellmin, Stefan Osswald, Christian Sticherling, Michael Kühne
Förderung
- Swiss Heart Foundation
Zitieren
APA
Badertscher, P., Weidlich, S., Knecht, S., Stauffer, N., Krisai, P., Voellmin, G., Osswald, S., Sticherling, C., & Kühne, M. (2023). Efficacy and safety of pulmonary vein isolation with pulsed field ablation vs. novel cryoballoon ablation system for atrial fibrillation. Europace, 25(12). https://doi.org/10.1093/europace/euad329
Vancouver
Badertscher P, Weidlich S, Knecht S, Stauffer N, Krisai P, Voellmin G, et al. Efficacy and safety of pulmonary vein isolation with pulsed field ablation vs. novel cryoballoon ablation system for atrial fibrillation. Europace. 2023;25(12). doi:10.1093/europace/euad329
BibTeX
@article{Badertscher2023,
author = {Badertscher, Patrick and Weidlich, Simon and Knecht, Sven and Stauffer, Niklas and Krisai, Philipp and Voellmin, Gian and Osswald, Stefan and Sticherling, Christian and Kühne, Michael},
title = {Efficacy and safety of pulmonary vein isolation with pulsed field ablation vs. novel cryoballoon ablation system for atrial fibrillation},
journal = {Europace},
year = {2023},
volume = {25},
number = {12},
doi = {10.1093/europace/euad329}
}
EUVIMED